Platelets are most important in providing cellular hemostasis but also take part in
inflammation and immune processes. Increased platelet size has been regarded as a …

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

Platelets are essential mediators of inflammation and thrombosis. Chronic obstructive
pulmonary disease (COPD) is a heterogeneous multisystem disease, causing significant …

Chronic airway diseases (CAD), mainly asthma and chronic obstructive pulmonary disease
(COPD), are frequently associated with different comorbidities. Among them, cardiovascular …

Chronic obstructive pulmonary disease (COPD) is considered one of the leading causes of
mortality. Cardiovascular comorbidities are diagnosed often in COPD patients, not only …

Older adults have a higher prevalence of chronic obstructive pulmonary disease (COPD),
which will likely increase substantially in the coming decades owing to aging populations …

Background Evidence suggests that chronic obstructive pulmonary disease (COPD) is
associated with a higher risk of lung carcinoma. Using a territory-wide clinical electronic …

Most patients with chronic obstructive pulmonary disease (COPD) suffer from at least one
additional, clinically relevant chronic disease. To a degree, the high global prevalence and …

Background: Polymorphisms and products of the cyclooxygenase (COX) pathway have
been associated with the development of chronic obstructive pulmonary disease (COPD) …

Introduction: Antiplatelet therapy has been associated with fewer exacerbations and
reduced respiratory symptoms in chronic obstructive pulmonary disease (COPD). Whether …